Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | AMGN | VRTX | REGN | GILD |
| Company | Akero Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 27.14 | 333.65 | 490.73 | 1,072.19 | 73.51 |
| High | 27.41 | 333.98 | 495.79 | 1,076.73 | 73.74 |
| Low | 26.28 | 328.43 | 489.07 | 1,060.74 | 71.96 |
| Last | 26.76 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Change | -0.32 | +0.32 | +3.45 | -3.66 | -0.95 |
| % Change | -1.18% | +0.10% | +0.71% | -0.34% | -1.29% |
| Volume | 686,900 | 1,848,800 | 1,691,700 | 452,200 | 5,571,800 |
| 20-Day Average Volume | 964,715 | 2,348,665 | 1,232,580 | 475,585 | 7,800,390 |
| Previous Close | 27.08 | 330.97 | 488.12 | 1,067.26 | 73.51 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.25 | 319.64 | 480.54 | 1,063.53 | 69.69 |
| 20-Day Raw Stochastic | 79.83% | 76.60% | 83.53% | 54.96% | 73.51% |
| 20-Day Relative Strength | 63.17% | 65.86% | 65.52% | 56.53% | 63.29% |
| Weighted Alpha | +57.71 | +40.56 | +40.92 | +43.37 | -7.73 |
| Today's Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 16% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.21% since 07/12/24 | +0.14% since 07/12/24 | +0.58% since 07/12/24 | -3.31% since 07/12/24 | +3.72% since 07/12/24 |
| Low | 25.63 on 07/15/24 | 327.87 on 07/15/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.21 on 07/15/24 |
| High | 28.21 on 07/16/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +20.76% since 06/18/24 | +8.27% since 06/18/24 | +5.20% since 06/18/24 | +2.36% since 06/18/24 | +14.90% since 06/18/24 |
| Low | 21.02 on 07/05/24 | 303.55 on 06/20/24 | 463.23 on 06/20/24 | 1,011.67 on 07/03/24 | 64.86 on 06/20/24 |
| High | 28.21 on 07/16/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | +28.90% since 04/19/24 | +23.19% since 04/19/24 | +24.68% since 04/19/24 | +18.60% since 04/19/24 | +8.69% since 04/19/24 |
| Low | 17.86 on 06/05/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 28.21 on 07/16/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | +22.14% since 01/19/24 | +7.63% since 01/19/24 | +13.00% since 01/19/24 | +13.95% since 01/19/24 | -16.87% since 01/19/24 |
| Low | 15.32 on 02/06/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 37.00 on 03/04/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,850,481 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 69,151 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -151,760,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -53,340,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | -0.28 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.90 on 05/10/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/09/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |